¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fibrin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fibrinoid necrosis
    ¼¶À¯¼Ò¸ð¾ç±«»ç, ÇǺ기¸ð¾ç±«»ç
  • fibrinolysin
    ¼¶À¯¼Ò¿ëÇØ¼Ò, ÇǺ기¿ëÇØ¼Ò
  • fibrinolysinemia
    ¼¶À¯¼Ò¿ëÇØ¼ÒÇ÷Áõ, ÇǺ기¿ëÇØ¼ÒÇ÷Áõ
  • fibrinolysis
    ¼¶À¯¼Ò¿ëÇØ, ÇǺ기¿ëÇØ
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØ-, ÇǺ기¿ëÇØ-
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É, ÇǺ기¿ëÇØ´É
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØÁ¦, ÇǺ기¿ëÇØÁ¦
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò, ÇǺ기¿ëÇØÈ¿¼Ò
  • fibrinopenia
    ¼¶À¯¼Ò°áÇÌ, ÇǺ기°áÇÌ
  • fibrinopeptide
    ¼¶À¯¼ÒÆéƼµå, ÇǺ긮³ëÆéƼµå
  • fibrinoplastic
    ¼¶À¯¼ÒÇü¼º-, ÇǺ기Çü¼º-
  • fibrinopurulent
    ¼¶À¯¼ÒÈ­³ó¼º-, ÇǺ기ȭ³ó¼º-
  • fibrinous gastritis
    ¼¶À¯¼ÒÀ§¿°, ÇǺ기À§¿°
  • fibrinous inflammation
    ¼¶À¯¼Ò¿°Áõ, ÇǺ기¿°Áõ
  • fibrinous iritis
    ¼¶À¯¼Òȫä¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØ-
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØ¹°Áú
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò
  • fibrinopenia
    ¼¶À¯¼Ò°áÇÌ
  • fibrinopeptide
    ¼¶À¯¼ÒÆéƼµå
  • fibrinoplastic
    ¼¶À¯¼ÒÇü¼º-
  • fibrinous gastritis
    ¼¶À¯¼ÒÀ§¿°
  • fibrinous inflammation
    ¼¶À¯¼Ò¿°Áõ
  • fibrinous iritis
    ¼¶À¯¼Òȫä¿°
  • fibrinous rhinitis
    ¼¶À¯¼ÒÄÚ¿°, ¼¶À¯¼Òºñ¿°
  • fibrinous synovitis
    ¼¶À¯¼ÒÀ±È°¸·¿°
  • fibrinuria
    ¼¶À¯¼Ò´¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fibrinoglobulin
    ¼¶À¯¼Ò±Û·ÎºÒ¸°.
  • fibrinoid necrosis
    ¼¶À¯¼Ò¾ç±«»ç
  • fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
  • fibrinokinase
    È­À̺긮³ëŰ<³ª>Á¦.
  • fibrinolysin
    ¼¶À¯¼Ò¿ëÇØ¼Ò
  • fibrinolysin
    ¼¶À¯¼ÒºÐÇØ(¡­ÝÂú°).
  • fibrinolysinemia =fibrinolysinaemia
    ¼¶À¯¼Ò¿ëÇØ¼Ò, ¼¶À¯¼Ò¿ëÇØ¼ÒÇ÷Áõ .
  • fibrinolysis
    ¼¶À¯¼Ò¿ëÇØ
  • fibrinolysis
    ¼¶À¯¼Ò¿ëÇØ.
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØÀÇ.
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØ¼º ¹°Áú.
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò.
  • fibrinolytic system
    ¼¶À¯¼Ò¿ëÇØ°è(éÁú°Í§)
  • fibrinolytics
    ¼¶À¯¼Ò¿ëÇØÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FD familial dysautonomia; family doctor; fan douche; fatal dose; fetal danger; fibrin derivative; fibro...
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
FIB Fellow of the Institute of Biology; fibrin; fibrinogen; fibrositis; fibula
fib fiber; fibrillation; fibrin; fibrinogen; fibula
FSF fibrin stabilizing factor; front surface fluorescence
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FGN Fibrin(ogen
FDP Fibrin(ogen) degradation product
FDP Fibrin-fibrinogen degradation product
FDP Fibrinogen-Fibrin Degradation Products
SF Soluble Fibrin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fibrinosis
    ¼¶À¯¼ÒÁõ
  • fibrinous exudate
    ¼¶À¯¼Ò¼º »ïÃâ¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
fibrinogen-fibrin conversion syndrome <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma.
(05 Mar 2000)
fibrinogenaemia An increased level of fibrinogen in the blood.
Synonym: fibrinogenaemia.
(05 Mar 2000)
fibrinogenase <enzyme> Protease (34 kD) generated in blood clotting that acts on fibrinogen to produce fibrin. Consists of two chains, A and B, linked by a disulphide bond. B chain has sequence homology with pancreatic serine proteases: cleaves at Arg Gly.
Thrombin is produced from prothrombin by the action either of the extrinsic system (tissue factor + phospholipid) or, more importantly, the intrinsic system (contact of blood with a foreign surface or connective tissue). Both extrinsic and intrinsic systems activate plasma factor X to form factor Xa which then, in conjunction with phospholipid (tissue derived or platelet factor 3) and factor V, catalyses the conversion.
(18 Nov 1997)
fibrinogenesis Formation or production of fibrin.
(05 Mar 2000)
fibrinogenic <physiology> Possessed of properties similar to fibrinogen; capable of forming fibrin. Pertaining to fibrinogen, producing fibrin.
(12 May 2002)
fibrinogenolysis The inactivation or dissolution of fibrinogen in the blood.
Origin: fibrinogen + G. Lysis, dissolution
(05 Mar 2000)
fibrinogenopenia A concentration of fibrinogen in the blood that is less than the normal.
Origin: fibrinogen + G. Penia, poverty
(05 Mar 2000)
fibrinogenous <physiology> Possessed of properties similar to fibrinogen; capable of forming fibrin. Pertaining to fibrinogen, producing fibrin.
(12 May 2002)
fibrinogens, abnormal Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.
(12 Dec 1998)
fibrinoid 1. Resembling fibrin.
2. A deeply or brilliantly acidophilic, homogeneous, refractile, proteinaceous material that: 1) is frequently formed in the walls of blood vessels and in connective tissue of patients with such diseases as disseminated lupus erythematosus, polyarteritis nodosa, scleroderma, dermatomyositis, and rheumatic fever; 2) is sometimes observed in healing wounds, chronic peptic ulcers, the placenta, necrotic arterioles of malignant hypertension, and other unrelated conditions.
Origin: fibrin + G. Eidos, resemblance
(05 Mar 2000)
fibrinoid necrosis Necrosis in which the necrotic tissue has some staining reactions resembling fibrin and becomes deeply eosinophilic, homogenous, and refractile.
(05 Mar 2000)
fibrinokinase Name proposed for the enzyme that converts plasminogen to plasmin; subsequently called urokinase, but now called plasminogen activator.
Synonym: fibrinolysokinase.
(05 Mar 2000)
fibrinolysin Synonym: plasmin.
(05 Mar 2000)
fibrinolysis <haematology> Solubilisation of fibrin in blood clots, chiefly by the proteolytic action of plasmin.
Origin: Gr. Lysis = dissolution
(12 Nov 1997)
fibrinolysokinase Name proposed for the enzyme that converts plasminogen to plasmin; subsequently called urokinase, but now called plasminogen activator.
Synonym: fibrinolysokinase.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Fibrinogen - »õâ Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.
    Synonyms : Blood Coagulation Factor I, gamma-Fibrinogen, Factor I, Coagulation, I, Coagulation Factor, gamma Fibrinogen
  • Fibrinogens, Abnormal - »õâ Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.
    Synonyms :
  • Fibrinolysis - »õâ The natural enzymatic dissolution of FIBRIN.
    Synonyms : Fibrinolyses
  • Fibrinolytic Agents - »õâ Fibrinolysin or agents that convert plasminogen to fibrinolysin (PLASMIN).
    Synonyms : Antithrombic Drugs, Fibrinolytic Drugs, Thrombolytic Drugs
  • Fibrinopeptide A - »õâ Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.
    Synonyms : Fibrinopeptides A, A, Fibrinopeptide, A, Fibrinopeptides
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
fibrinolysis a normal ongoing process that dissolves fibrin and results in the removal of small blood clots; "drugs causing fibrinolysis have been utilized therapeutically"
Ãâó: wordnet.princeton.edu/perl/webwn
fibrinopeptide peptide released from the amino end of fibrinogen by the action of thrombin to form fibrin during clotting of the blood
Ãâó: wordnet.princeton.edu/perl/webwn
fibrin bodies of pleura movable or adherent, round, homogeneous, sharply demarcated opacities near the base of the pleural cavity, which may occur secondary to pleural effusion, pneumothorax, or hemopneumothorax; called also pleural fibrin balls.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
fibrinous inflammation one that is characterized by an exudate of coagulated fibrin.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
fibrinous polyp an intrauterine polyp made up of fibrin from retained blood; it may grow from portions of an ovum or from a thrombus at the placental site.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á